Network Pharmacology
Driving Discovery & Development for Efficacious Drugs
February 19-20, 2012

Network pharmacology is an emerging field in pharmaceutical discovery and development, enabling researchers to better understand drug mechanisms of action. Join your peers at Cambridge Healthtech Institute’s Inaugural Network Pharmacology symposium.  As industry looks inward to solve the challenge of compound/molecule attrition in late-phase clinical trials, novel multidimensional approaches are being utilized to better understand lead molecules in the pre-clinical phase.  For many years, pharmaceutical scientists have known that some of the most efficacious oncology drugs have activity that would be considered “polypharmacology,” eschewing the idea of one drug for one target. Meet experts across a range of therapeutic areas who can show how multiple target efficacy can be a way forward for drug development.  Drawing from pharmacogenomics, target identification, in silico modeling, assay development, and systems biology, network pharmacology uses available information to better understand multiple target effects of various molecules.  Network pharmacology also plays a role in accelerating drug repositioning and repurposing.  This symposium will bring together experts from across drug discovery and development, from industry, academic and government organizations, to present network pharmacology technologies, strategies and approaches. Listen to case studies from both small and large molecule development, as well as participate in panel discussions on implementing network pharmacology.

Who should attend: Clinical pharmacologists, informatics specialists, systems biologists,  pharmaceutical leaders, drug reposition experts, pre-clinical pharmacologists, ADME/tox specialists, lead validation experts, target identification experts, as well as researchers in oncology, inflammation, cardiovascular, neurology and anyone interested in new technologies & methods for better predicting efficacious drugs.

Topics will include, but are not limited to:

  • Network pharmacology
  • Mechanism of action
  • Drug action
  • Drug targeting
  • Polypharmacology
  • Pharmacogenomics
  • In silico modeling
  • Bioinformatics
  • Cheminformatics
  • Drug repositioning
  • Drug repurposing
  • Network biology
  • Systems biology
  • Computational biology
  • Target identification
  • Target validation

If you would like to submit a proposal to give a presentation at this meeting, please click here to submit a title and brief 1-2 sentence summary (up to a maximum of 40 words) of a proposed topic on your recent work in the area of Network Pharmacology.

The deadline for submission is July 29, 2011.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For details on the conference, please contact: 
Kate Skaare 
Conference Producer
Cambridge Healthtech Institute
T: (+1) 781-972-5406

For partnering and sponsorship information, please contact:
Jon Stroup
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483

Joseph Vacca
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431

Premier Sponsors:   


Jackson Laboratory - small logo  


 Precision for Medicine 


Silicon Biosystems 

Thomson Reuters-Large